Biblio Discovery — Demo Discovery Service

7 results for "Talbot, Alice"

Showing 1–7 · 0.19 seconds · RSS

  1. Journal Article Full text

    Improving the documentation of FIO(2) for arterial blood gases

    Crowle, Daniel; Talbot, Alice

    Future Healthc J · 2023 · English · PubMed Central

  2. Journal Article Full text

    The contribution of Lynch syndrome to early onset malignancy in Ireland

    Talbot, Alice; O’Donovan, Emily; Berkley, Eileen et al.

    BMC Cancer · 2021 · English · PubMed Central

    BACKGROUND: Lynch syndrome (LS) is an autosomal dominant hereditary cancer syndrome responsible for 2–4% of hereditary colorectal cancers (CRC). Mismatch repair protein deficiency (dMMR) is a characteristic feature of LS. It has been associated with a poor response to standard chemotherapy in…

  3. Book Full text

    Becoming Byzantine: children and childhood in Byzantium

    Papaconstantinou, Arietta; Talbot, Alice-Mary

    Harvard University Press · 2009 · English · HAL

    International audience

  4. Journal Article Full text

    The impact of the 2022 Ukraine/Russian conflict on cancer clinical trials

    Talbot, Alice; Connor, Sophia G.; Austin, Kate et al.

    J Int Med Res · 2022 · English · PubMed Central

    Since the invasion of Ukraine in February 2022, clinical trial conduct has become extremely challenging due to damage to the healthcare infrastructure and patient displacement. This current study aimed to estimate the number of cancer clinical trials at risk of impact from the conflict. A…

  5. Journal Article Full text

    Solute carrier family 16 member 1 as a potential prognostic factor for pancreatic ductal adenocarcinoma and its influence on tumor immunity

    Wang, Meng; Liu, Lin; Li, Xinze et al.

    J Gastrointest Oncol · 2024 · English · PubMed Central

    BACKGROUND: Solute carrier family 16 member 1 (SLC16A1) serves as a biomarker in numerous types of cancer. Tumor immune infiltration has drawn increasing attention in cancer progression and treatment. The objective of our study was to explore the association between SLC16A1 and the tumor immune…

  6. Journal Article Full text

    Overall survival and treatment modalities in pancreatic adenocarcinoma: a retrospective analysis of a single centre in Western Australia

    Talbot, Alice; Talbot, Thomas; Shaughnessy, Emma et al.

    J Gastrointest Oncol · 2023 · English · PubMed Central

    BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) has a 5-year survival rate of approximately 10.7% in Australia. It is becoming an increasingly common cause of cancer mortality. The therapeutic model for PDAC remains limited, especially for those with metastatic disease on presentation. METHODS…